MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.
Cells. 2023 Mar 14;12(6):896. doi: 10.3390/cells12060896.
The haematopoietic system plays an essential role in our health and survival. It is comprised of a range of mature blood and immune cell types, including oxygen-carrying erythrocytes, platelet-producing megakaryocytes and infection-fighting myeloid and lymphoid cells. Self-renewing multipotent haematopoietic stem cells (HSCs) and a range of intermediate haematopoietic progenitor cell types differentiate into these mature cell types to continuously support haematopoietic system homeostasis throughout life. This process of haematopoiesis is tightly regulated in vivo and primarily takes place in the bone marrow. Over the years, a range of in vitro culture systems have been developed, either to expand haematopoietic stem and progenitor cells or to differentiate them into the various haematopoietic lineages, based on the use of recombinant cytokines, co-culture systems and/or small molecules. These approaches provide important tractable models to study human haematopoiesis in vitro. Additionally, haematopoietic cell culture systems are being developed and clinical tested as a source of cell products for transplantation and transfusion medicine. This review discusses the in vitro culture protocols for human HSC expansion and differentiation, and summarises the key factors involved in these biological processes.
造血系统在我们的健康和生存中起着至关重要的作用。它由一系列成熟的血液和免疫细胞类型组成,包括携带氧气的红细胞、产生血小板的巨核细胞以及抗感染的髓系和淋巴系细胞。自我更新的多能造血干细胞(HSCs)和一系列中间造血祖细胞类型分化为这些成熟细胞类型,以在整个生命周期中持续支持造血系统的稳态。造血过程在体内受到严格调控,主要发生在骨髓中。多年来,已经开发出多种体外培养系统,这些系统要么基于使用重组细胞因子、共培养系统和/或小分子来扩增造血干细胞和祖细胞,要么将它们分化为各种造血谱系。这些方法为研究体外人类造血提供了重要的可处理模型。此外,正在开发造血细胞培养系统并进行临床试验,作为移植和输血医学中细胞产品的来源。本文综述了人类 HSC 扩增和分化的体外培养方案,并总结了这些生物学过程中涉及的关键因素。